BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
22 results:

  • 1. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
    Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis.
    Khanmohammadi S; Behnoush AH; Akhlaghpoor S
    PLoS One; 2023; 18(8):e0289975. PubMed ID: 37585405
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pentacyclic Triterpenes from Olive Leaves Formulated in Microemulsion: Characterization and Role in De Novo Lipogenesis in HepG2 Cells.
    Vasarri M; Degl'Innocenti D; Albonetti L; Bilia AR; Bergonzi MC
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569488
    [No Abstract]    [Full Text] [Related]  

  • 4. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal liver Metastases.
    Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
    Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Lüdemann W; Kahn J; Pustelnik D; Hardt J; Böning G; Jonczyk M; Amthauer H; Gebauer B; Hamm B; Wieners G
    Eur Radiol; 2022 Jul; 32(7):4687-4698. PubMed ID: 35230518
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    van 't Erve I; Wesdorp NJ; Medina JE; Ferreira L; Leal A; Huiskens J; Bolhuis K; van Waesberghe JTM; Swijnenburg RJ; van den Broek D; Velculescu VE; Kazemier G; Punt CJA; Meijer GA; Fijneman RJA
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34820593
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Ghani MA; Fereydooni A; Chen E; Letzen B; Laage-Gaupp F; Nezami N; Deng Y; Gan G; Thakur V; Lin M; Papademetris X; Schernthaner RE; Huber S; Chapiro J; Hong K; Georgiades C
    Eur Radiol; 2021 Dec; 31(12):8858-8867. PubMed ID: 34061209
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation.
    Masperi A; Cubadda V; Bombelli L; Labruna R; Bagnardi V; Fodor CI; Pagan E; Bonomo G; Orsi F
    Abdom Radiol (NY); 2021 Jul; 46(7):3448-3455. PubMed ID: 33630128
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
    Bocheva Y; Bochev P; Chaushev B; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.
    Lee YH; Hsia CY; Hsu CY; Huang YH; Lin HC; Huo TI
    World J Surg; 2013 Jun; 37(6):1348-55. PubMed ID: 23467925
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence.
    Toso C; Cader S; Mentha-Dugerdil A; Meeberg G; Majno P; Morard I; Giostra E; Berney T; Morel P; Mentha G; Kneteman NM
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):342-7. PubMed ID: 22710887
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases.
    Simoneau E; Aljiffry M; Salman A; Abualhassan N; Cabrera T; Valenti D; El Baage A; Jamal M; Kavan P; Al-Abbad S; Chaudhury P; Hassanain M; Metrakos P
    HPB (Oxford); 2012 Jul; 14(7):461-8. PubMed ID: 22672548
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection.
    Ochiai T; Ikoma H; Okamoto K; Kokuba Y; Sonoyama T; Otsuji E
    World J Surg; 2012 Jan; 36(1):136-43. PubMed ID: 22051887
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Hsu CY; Huang YH; Chiou YY; Su CW; Lin HC; Lee RC; Chiang JH; Huo TI; Lee FY; Lee SD
    Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Chiang JH; Lee PC; Lee SD
    BMC Gastroenterol; 2010 Dec; 10():146. PubMed ID: 21194431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
    Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
    J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Role of TT virus in pathogenesis of liver diseases--the prevalence of ttv in patients and healthy individuals].
    Liwen I; Januszkiewicz-Lewandowska D; Nowak J
    Przegl Epidemiol; 2002; 56(1):101-13. PubMed ID: 12150053
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group.
    Bosset JF; Horiot JC; Hamers HP; Cionini L; Bartelink H; Caspers R; Untereiner M; Ciambelloti E; Pierart M; Van Glabbeke M
    Radiother Oncol; 2001 Oct; 61(1):7-13. PubMed ID: 11578723
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Virus hepatitis update.
    Summerfield JA
    J R Coll Physicians Lond; 2000; 34(4):381-5. PubMed ID: 11005078
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.